Cystic fibrosis is a genetic disease caused by mutations
in the
gene for the cystic fibrosis transmembrane conductance regulator (CFTR)
protein. In vitro experiments have demonstrated that 4-methyl-2-(5-phenyl-1H-pyrazol-3-yl)phenol (VRT-532, 1) is able
to partially restore the function of mutant CFTR proteins. To help
elucidate the nature of the interactions between 1 and
mutant CFTR, molecular probes based on the structure of 1 have been prepared. These include a photoreactive aryl azide derivative 11 and a fluorescent dansyl sulfonamide 15. Additionally,
a method for hydrogen isotope exchange on 1 has been
developed, which could be used for the incorporation of radioactive
tritium. Using iodide efflux assays, the probe molecules have been
demonstrated to modulate the activity of mutant CFTR in the same manner
as 1. These probe molecules enable a number of biochemical
experiments aimed at understanding how 1 rescues the
function of mutant CFTR. This understanding can in turn aid in the
design and development of more efficacious compounds which may serve
as therapeutic agents in the treatment of cystic fibrosis.